Cantitate/Preț
Produs
Total produse
Vezi coșul
Tamoxifen: Pioneering Medicine in Breast Cancer de Philipp Y. Maximov

Tamoxifen: Pioneering Medicine in Breast Cancer: Milestones in Drug Therapy

Autor Philipp Y. Maximov, Russell E. McDaniel, V. Craig Jordan
en Limba Engleză Hardback – 6 aug 2013
Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.
This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 121182 lei  6-8 săpt.
  Springer – 8 feb 2015 121182 lei  6-8 săpt.
Hardback (1) 121784 lei  6-8 săpt.
  Springer – 6 aug 2013 121784 lei  6-8 săpt.

Din seria Milestones in Drug Therapy

  • 5% Gene Therapy for Autoimmune and Inflammatory Diseases
    Preț: 133508 lei
  • 5% Treatment of Psoriasis
    Preț: 84004 lei
  • 5% Valproate
    Preț: 35233 lei
  • 5% Modern Immunosuppressives
    Preț: 34630 lei
  • 5% Cognitive Enhancing Drugs
    Preț: 67398 lei
  • 5% Fluoroquinolone Antibiotics
    Preț: 68320 lei
  • 5% Glucocorticoids
    Preț: 61447 lei
  • 5% Drugs Targeting B-Cells in Autoimmune Diseases
    Preț: 104469 lei
  • 5% Atypical Antipsychotics
    Preț: 133281 lei
  • 5% Glucocorticoids
    Preț: 34542 lei
  • 5% Pharmacotherapy of Obesity
    Preț: 66735 lei
  • 5% Glutamate-based Therapies for Psychiatric Disorders
    Preț: 103569 lei
  • 5% Methotrexate
    Preț: 34213 lei
  • 5% HMG-CoA Reductase Inhibitors
    Preț: 67121 lei
  • 5% ACE Inhibitors
    Preț: 34596 lei
  • 5% COX-2 Inhibitors
    Preț: 104122 lei
  • 5% Recombinant Protein Drugs
    Preț: 103844 lei
  • 5% Proton Pump Inhibitors
    Preț: 121612 lei
  • 5% Antidepressants
    Preț: 60764 lei
  • 5% Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use
    Preț: 104244 lei
  • 5% Sildenafil
    Preț: 152172 lei
  • 5% Twenty Years of G-CSF: Clinical and Nonclinical Discoveries
    Preț: 135030 lei
  • 5% Aromatase Inhibitors
    Preț: 67169 lei
  • 5% Anxiolytics
    Preț: 67277 lei
  • 5% Cannabinoids as Therapeutics
    Preț: 170611 lei
  • 5% Calcium Channel Blockers
    Preț: 104210 lei
  • 5% PEGylated Protein Drugs: Basic Science and Clinical Applications
    Preț: 134073 lei
  • 5% Hepatitis Prevention and Treatment
    Preț: 103482 lei
  • 5% Bortezomib in the Treatment of Multiple Myeloma
    Preț: 67883 lei
  • 5% Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology
    Preț: 68041 lei
  • 5% Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD
    Preț: 67761 lei
  • 5% Drugs for HER-2-positive Breast Cancer
    Preț: 102737 lei
  • 5% Combination Therapy of AIDS
    Preț: 103375 lei
  • 5% Influenza Virus Sialidase - A Drug Discovery Target
    Preț: 103520 lei
  • 5% Macrolide Antibiotics
    Preț: 104504 lei

Preț: 121784 lei

Preț vechi: 128193 lei
-5% Nou

Puncte Express: 1827
Preț estimativ în valută:
23311€ • 25064$ • 19433£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783034806633
ISBN-10: 3034806639
Pagini: 250
Ilustrații: XXII, 199 p. 54 illus.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.48 kg
Ediția:2013
Editura: Springer
Colecția Springer
Seria Milestones in Drug Therapy

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Discovery and Pharmacology of Nonsteroidal Estrogens and Antiestrogens.- Tamoxifen Goes Forward Alone.- Metabolites of Tamoxifen as the Basis of Drug Development.- Adjuvant Therapy – The Breakthrough.- The Wisconsin Story in the 1980’s: Discovery of Target Site Specific Estrogen Action.- Carcinogenesis and Tamoxifen.- Chemoprevention: Cinderella waiting for the ball.- Tamoxifen and Raloxifene head to head: The STAR TRIAL.- Acquired resistance to Tamoxifen: back to the beginning.- The legacy of Tamoxifen.- Appendix: Four decades of discovery in breast cancer research and treatment – an interview with V. Craig Jordan by Marc Poirot.- Selected Awards that Recognize the Contribution of Tamoxifen and Raloxifene to Medicine.

Recenzii

From the book reviews:
“This is a book that had to be written. … This book should be available in every oncology department. The story will interest clinicians and laboratory scientists alike. It has both historical value and value as a guide that will illuminate the path to successful involvement in cancer research for younger cancer researchers.” (R. M. Lowenthal, Inflammopharmacology, Vol. 22 (3), June, 2014)
“This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. … It is a well-done and interesting read.” (Thomas L. Pazdernik, Doody’s Book Reviews, November, 2013)

Textul de pe ultima copertă

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.
This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.

Caracteristici

The story of Tamoxifen written first-hand by the "father of tamoxifen" A personal journey through four decades of discovery that changed women’s health Including an interview with the pioneer of the therapy Includes supplementary material: sn.pub/extras